These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 5896108)

  • 21. [A study on urinary fungal infection].
    Takeuchi H; Arai Y; Konami T; Ikeda T; Tomoyoshi T; Tatewaki K
    Hinyokika Kiyo; 1983 Oct; 29(10):1273-7. PubMed ID: 6100418
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk factors for nosocomial candiduria.
    Guler S; Ural O; Findik D; Arslan U
    Saudi Med J; 2006 Nov; 27(11):1706-10. PubMed ID: 17106546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Virulence of candida-like fungi, isolated from the urogenital tract (author's transl)].
    Szarmach H; Małyszko E; Wroński A; Niczyporuk W
    Z Hautkr; 1981 Oct; 56(19):1265-74. PubMed ID: 7032102
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factors for nosocomial candiduria due to Candida glabrata and Candida albicans.
    Harris AD; Castro J; Sheppard DC; Carmeli Y; Samore MH
    Clin Infect Dis; 1999 Oct; 29(4):926-8. PubMed ID: 10589912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. To treat or not to treat--critically ill patients with candiduria.
    Hollenbach E
    Mycoses; 2008 Sep; 51 Suppl 2():12-24. PubMed ID: 18721329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Value of hypertonic media for the isolation of aberrant forms of Candida albicans from women with lower genital tract infections].
    Ataoğlu H; Güngör C; Aksoy E; Ortaç F
    Mikrobiyol Bul; 1993 Oct; 27(4):338-43. PubMed ID: 8264447
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emerging microbiological trends in Candiduria.
    Paul N; Mathai E; Abraham OC; Mathai D
    Clin Infect Dis; 2004 Dec; 39(11):1743-4. PubMed ID: 15578392
    [No Abstract]   [Full Text] [Related]  

  • 28. [Epidemiological features of Candida infections detected in intensive care units and risk factors affecting mortality].
    Acar A; Oncül O; Küçükardali Y; Ozyurt M; Haznedaroğlu T; Cavuşlu S
    Mikrobiyol Bul; 2008 Jul; 42(3):451-61. PubMed ID: 18822889
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary isolation of Candida species from urine specimens using chromogenic medium.
    Okulicz JF; Rivard RG; Conger NG; Nguyen MX; Hospenthal DR
    Mycoses; 2008 Mar; 51(2):141-6. PubMed ID: 18254751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Occult bacterial lower urinary tract infections in cats-urinalysis and culture findings.
    Litster A; Moss S; Platell J; Trott DJ
    Vet Microbiol; 2009 Apr; 136(1-2):130-4. PubMed ID: 19056189
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Measures during bladder catheterization and trans-uretral instrumentation].
    Fritjofsson A
    Lakartidningen; 1969 Aug; 66(33):3240-2. PubMed ID: 5393070
    [No Abstract]   [Full Text] [Related]  

  • 32. Candidiasis of the urinary tract.
    Hill JT
    Proc R Soc Med; 1974 Nov; 67(11):1155-6. PubMed ID: 4612541
    [No Abstract]   [Full Text] [Related]  

  • 33. [Prevalence of Candida albicans and Candida non-albicans in clinical samples during 1999-2001].
    Mujica MT; Finquelievich JL; Jewtuchowicz V; Iovannitti CA
    Rev Argent Microbiol; 2004; 36(3):107-12. PubMed ID: 15559191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Fungal infections in urologic diseases with special reference to mixed bacterial infection].
    Meissner B; Friedrich E; Anger G; Streich U; Schulz H
    Z Urol Nephrol; 1982 Apr; 75(4):223-7. PubMed ID: 7048800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Asymptomatic candiduria. Prognosis, complications and some other clinical considerations.
    Schönebeck J
    Scand J Urol Nephrol; 1972; 6(2):136-46. PubMed ID: 5064886
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparison of three differential media for the presumptive identification of yeasts.
    Yucesoy M; Ozbek OA; Marol S
    Clin Microbiol Infect; 2005 Mar; 11(3):245-7. PubMed ID: 15715727
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In-vitro activity and in-vivo efficacy of catheters impregnated with chloroxylenol and thymol against uropathogens.
    Mansouri MD; Darouiche RO
    Clin Microbiol Infect; 2008 Feb; 14(2):190-2. PubMed ID: 18042195
    [No Abstract]   [Full Text] [Related]  

  • 38. Prospective multicenter surveillance study of funguria in hospitalized patients. The National Institute for Allergy and Infectious Diseases (NIAID) Mycoses Study Group.
    Kauffman CA; Vazquez JA; Sobel JD; Gallis HA; McKinsey DS; Karchmer AW; Sugar AM; Sharkey PK; Wise GJ; Mangi R; Mosher A; Lee JY; Dismukes WE
    Clin Infect Dis; 2000 Jan; 30(1):14-8. PubMed ID: 10619726
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bacterial interference for prevention of urinary tract infection: a prospective, randomized, placebo-controlled, double-blind pilot trial.
    Darouiche RO; Thornby JI; Cerra-Stewart C; Donovan WH; Hull RA
    Clin Infect Dis; 2005 Nov; 41(10):1531-4. PubMed ID: 16231269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Therapy of candiduria by alkalinization of urine. Oral treatment with potassium-sodium-hydrogen citrate].
    Strassner C; Friesen A
    Fortschr Med; 1995 Sep; 113(25):359-62. PubMed ID: 7498850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.